• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Daratumumab for multidrug-resistant phospholipase-A2 receptor-related membranous nephropathy.

作者信息

Vink Coralien H, van Cranenbroek Bram, van der Heijden Joost W, Koenen Hans P J M, Wetzels Jack F M

机构信息

Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands.

Department of Immunology, Radboud University Medical Center, Nijmegen, the Netherlands.

出版信息

Kidney Int. 2022 Mar;101(3):646-647. doi: 10.1016/j.kint.2021.12.019.

DOI:10.1016/j.kint.2021.12.019
PMID:35190038
Abstract
摘要

相似文献

1
Daratumumab for multidrug-resistant phospholipase-A2 receptor-related membranous nephropathy.达雷妥尤单抗用于治疗多药耐药的磷脂酶A2受体相关膜性肾病。
Kidney Int. 2022 Mar;101(3):646-647. doi: 10.1016/j.kint.2021.12.019.
2
Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.抗磷脂酶A2受体抗体与膜性肾病的免疫抑制：抗磷脂酶A2受体自身抗体致病性的更多证据
J Am Soc Nephrol. 2015 Oct;26(10):2308-11. doi: 10.1681/ASN.2015020181. Epub 2015 Mar 24.
3
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.原发性膜性肾病患者的M型磷脂酶A2受体自身抗体与肾功能
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29.
4
Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.抗磷脂酶A2受体自身抗体指导下的膜性肾病诊断与治疗：一种新的个性化医疗方法。
Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1341-3. doi: 10.2215/CJN.05880614. Epub 2014 Jul 17.
5
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy.抗磷脂酶A2受体自身抗体：原发性膜性肾病治疗的一大进展
Biomed Res Int. 2015;2015:249740. doi: 10.1155/2015/249740. Epub 2015 Oct 20.
6
Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues.膜性肾病中的磷脂酶A2受体抗体：未解决的问题
J Am Soc Nephrol. 2014 Jun;25(6):1137-9. doi: 10.1681/ASN.2014010091. Epub 2014 Mar 7.
7
Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.利妥昔单抗对伴有抗磷脂酶A2受体抗体滴度持续升高的膜性肾病进行再治疗。
Kidney Int. 2019 Jan;95(1):233-234. doi: 10.1016/j.kint.2018.08.045.
8
Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.循环抗磷脂酶A2受体自身抗体用于监测膜性肾病的免疫活性。
J Am Soc Nephrol. 2011 Aug;22(8):1400-2. doi: 10.1681/ASN.2011060610. Epub 2011 Jul 22.
9
Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment.奥妥珠单抗治疗对治疗耐药的PLA2R阳性膜性肾小球肾炎
Nefrologia (Engl Ed). 2024 Mar-Apr;44(2):306-307. doi: 10.1016/j.nefroe.2024.03.004. Epub 2024 Apr 16.
10
Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.两种不同免疫抑制方案治疗的特发性膜性肾病患者中M型磷脂酶A2受体抗体滴度动态变化的预后价值
Biomarkers. 2015 Feb;20(1):77-83. doi: 10.3109/1354750X.2014.993708. Epub 2014 Dec 18.

引用本文的文献

1
An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes.关于与肾病综合征相关疾病的最新综合综述
Biomedicines. 2024 Oct 4;12(10):2259. doi: 10.3390/biomedicines12102259.
2
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.评估非扎妥单抗在抗磷脂酶A2受体自身抗体阳性原发性膜性肾病中的安全性和有效性的1b/2a期研究
Kidney Int Rep. 2024 Jun 20;9(9):2635-2647. doi: 10.1016/j.ekir.2024.06.018. eCollection 2024 Sep.
3
Therapeutic targets in membranous nephropathy: plasma cells and complement.
膜性肾病的治疗靶点：浆细胞与补体
Clin Kidney J. 2024 Aug 13;17(9):sfae243. doi: 10.1093/ckj/sfae243. eCollection 2024 Sep.
4
Ten tips on immunosuppression in primary membranous nephropathy.原发性膜性肾病免疫抑制治疗的十条建议。
Clin Kidney J. 2024 Apr 29;17(6):sfae129. doi: 10.1093/ckj/sfae129. eCollection 2024 Jun.
5
Application of CD38 monoclonal antibody in kidney disease.CD38 单克隆抗体在肾脏病中的应用。
Front Immunol. 2024 May 10;15:1382977. doi: 10.3389/fimmu.2024.1382977. eCollection 2024.
6
How to Choose the Right Treatment for Membranous Nephropathy.如何为膜性肾病选择正确的治疗方法。
Medicina (Kaunas). 2023 Nov 14;59(11):1997. doi: 10.3390/medicina59111997.
7
Treatment of membranous nephropathy: Perspectives on current and future therapies.膜性肾病的治疗：当前及未来治疗方法的展望
Front Nephrol. 2023 Jan 27;3:1110355. doi: 10.3389/fneph.2023.1110355. eCollection 2023.
8
Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy.原发性膜性肾病中单克隆抗体治疗的应用进展。
Drugs. 2023 Apr;83(6):507-530. doi: 10.1007/s40265-023-01855-y. Epub 2023 Apr 5.
9
Novel Treatments Paradigms: Membranous Nephropathy.新型治疗模式：膜性肾病
Kidney Int Rep. 2023 Jan 2;8(3):419-431. doi: 10.1016/j.ekir.2022.12.011. eCollection 2023 Mar.